Dnm2tm2.1Ics
Targeted Allele Detail
|
Symbol: |
Dnm2tm2.1Ics |
Name: |
dynamin 2; targeted mutation 2.1, Mouse Clinical Institute |
MGI ID: |
MGI:6506378 |
Synonyms: |
Dnm2K562E |
Gene: |
Dnm2 Location: Chr9:21336204-21419055 bp, + strand Genetic Position: Chr9, 7.79 cM
|
Alliance: |
Dnm2tm2.1Ics page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:288372
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutation: |
|
Single point mutation
|
|
|
Mutation details: Exon 16 was replaced with one containing an A-to-G nucleotide change resulting in a lysine to glutamic acid substitution at amino acid 562 (p.K562E). In addition, protamine, cre- and selection marker cassettes flanked by loxP sites were inserted in intron 16-17 which were removed via cre-mediated recombination. The K562E mutation is associated with dominant-intermediate Charcot-Marie-Tooth type B disease.
(J:288372)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Dnm2 Mutation: |
100 strains or lines available
|
|
Original: |
J:288372 Pereira JA, et al., Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy. Hum Mol Genet. 2020 May 28;29(8):1253-1273 |
All: |
1 reference(s) |
|